What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to report Elevance Health's (Anthem, Inc.) financial results for the first quarter ended March 31, 2019, through an accompanying press release.

Where can I find the specific financial results discussed in this report?

The specific financial results are detailed in the press release furnished as Exhibit 99.1 to this 8-K filing. This press release provides the company's financial performance for the first quarter of 2019.

Are the financial results in the press release legally binding as if they were filed?

No, the information furnished in the press release (Item 2.02 and Exhibit 99.1) is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This means it does not carry the same legal liability as if it were formally filed.

What kind of risks does Elevance Health warn investors about in this filing?

Elevance Health warns investors about a wide range of risks that could affect future performance. These include regulatory changes (such as those related to the ACA), evolving healthcare costs and utilization, competitive pressures, enrollment fluctuations, data security breaches, risks associated with government programs like Medicare and Medicaid, litigation (including disputes with Cigna), and operational challenges with pharmacy benefit management services.

ELV 8-K: Earnings & Results

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed this 8-K report on April 24, 2019, to announce its first-quarter financial results for the period ending March 31, 2019. The filing primarily consists of a press release detailing these results, which is furnished as an exhibit. Investors should note that while the press release provides key financial information, it is furnished, not filed, under Section 18 of the Securities Exchange Act of 1934, meaning it does not carry the same legal implications as a filed document. The report also includes a comprehensive section on forward-looking statements. This section outlines the inherent risks and uncertainties that could cause actual results to differ materially from management's projections. Investors are urged to review these risks, which cover a broad range of factors including regulatory changes (like the ACA), healthcare cost trends, provider contracts, premium rate approvals, competitive pressures, enrollment trends, data security, government program risks (Medicare/Medicaid), quality ratings, product mix, litigation, pharmacy benefit management (PBM) agreements, capital requirements, share repurchases, dividends, indebtedness, financial strength ratings, publicity, information systems, Blue Cross Blue Shield licenses, and potential M&A impacts. The extensive list of potential risks underscores the complex operating environment for health insurers.

Key Highlights

1The 8-K filing reports Elevance Health's (Anthem, Inc.) first-quarter 2019 financial results.
2The core of the filing is a press release detailing Q1 2019 financial performance.
3The press release is furnished as Exhibit 99.1 and is incorporated by reference.
4Information furnished in this report is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934.
5The filing includes a detailed 'Forward-Looking Statements' section highlighting numerous risks and uncertainties.
6Key risk factors mentioned include regulatory changes (ACA), healthcare cost trends, competitive landscape, and PBM-related agreements.

Elevance Health, Inc. 8-K Report, Financial Results (Apr 24, 2019)

Summary

Key Highlights

Frequently Asked Questions